Northern Trust Corp Edwards Lifesciences Corp Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Northern Trust Corp holds 5,716,261 shares of EW stock, worth $376 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

5,716,261

Previous 5,765,361 0.85%

Holding current value

$376 Million

Previous $551 Million 4.16%

% of portfolio

0.09%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $4.14 Million - $4.63 Million	-49,100 Reduced 0.85%	5,716,261 $528 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $13.6 Million - $17.9 Million	-186,889 Reduced 3.14%	5,765,361 $551 Million
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $25 Million - $31.5 Million	-405,223 Reduced 6.37%	5,952,250 $454 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $16.7 Million - $22.5 Million	241,347 Added 3.95%	6,357,473 $440 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $35.4 Million - $41 Million	-434,642 Reduced 6.63%	6,116,126 $577 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $1.22 Million - $1.39 Million	16,469 Added 0.25%	6,550,768 $542 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $2.37 Million - $3.03 Million	34,664 Added 0.53%	6,534,299 $488 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $7.36 Million - $9.59 Million	-89,395 Reduced 1.36%	6,499,635 $537 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $13.2 Million - $19.6 Million	-152,687 Reduced 2.26%	6,589,030 $627 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $3.79 Million - $4.78 Million	-37,218 Reduced 0.55%	6,741,717 $794 Million
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $1.28 Million - $1.57 Million	12,042 Added 0.18%	6,778,935 $878 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $7.81 Million - $9.31 Million	75,851 Added 1.13%	6,766,893 $766 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $8 Million - $10 Million	-95,426 Reduced 1.41%	6,691,042 $693 Million
Q1 2021 May 12, 2021	SELL	$78.68 - $90.67 $143,197 - $165,019	-1,820 Reduced 0.03%	6,786,468 $568 Million
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $19.4 Million - $24.6 Million	-270,042 Reduced 3.83%	6,788,288 $619 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $4.1 Million - $5.33 Million	-60,991 Reduced 0.86%	7,058,330 $563 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $275 Million - $368 Million	4,776,572 Added 203.89%	7,119,321 $492 Million
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $1.32 Million - $2.04 Million	-25,134 Reduced 1.06%	2,342,749 $442 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $824,550 - $944,035	-11,500 Reduced 0.48%	2,367,883 $552 Million
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $2.66 Million - $3.26 Million	-43,216 Reduced 1.78%	2,379,383 $523 Million
Q2 2019 Aug 13, 2019	BUY	$55.74 - $64.41 $2.73 Million - $3.15 Million	48,931 Added 2.06%	2,422,599 $448 Million
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $1.08 Million - $1.44 Million	22,536 Added 0.96%	2,373,668 $454 Million
Q4 2018 Feb 12, 2019	BUY	$46.41 - $56.94 $3.5 Million - $4.29 Million	75,391 Added 3.31%	2,351,132 $360 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $4.88 Million - $6.2 Million	-106,847 Reduced 4.48%	2,275,741 $396 Million
Q2 2018 Sep 18, 2018	SELL	$42.45 - $51.3 $570,867 - $689,882	-13,448 Reduced 0.56%	2,382,588 $347 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $595,106 - $719,174	14,019 Added 0.59%	2,396,036 $349 Million
Q1 2018 May 09, 2018	SELL	$37.19 - $47.45 $1.43 Million - $1.82 Million	-38,356 Reduced 1.58%	2,382,017 $332 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $1.11 Million - $1.29 Million	-32,770 Reduced 1.34%	2,420,373 $273 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $89 Million - $95.3 Million	2,453,143	2,453,143 $268 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Edwards Lifesciences Corp Transaction History